Mr. Michael Gray
business and management
Arsanis BioSceiences
United Kingdom
Biography
Mr. Gray comes to Arsanis from Curis, Inc. (NASDAQ: CRIS) where he held a variety of leadership positions over the past 15 years, including chief financial officer, chief business officer and chief operating officer, and was instrumental in financial and business development transactions that raised over $350 million. At Arsanis, Mr. Gray will lead financial strategy, planning and operations as well as corporate and business development initiatives as the company continues to advance its deep clinical and pre-clinical pipeline of precision monoclonal antibodies for serious infectious diseases. Mr. Gray comes to Arsanis from Curis, Inc. (NASDAQ: CRIS) where he held a variety of leadership positions over the past 15 years, including chief financial officer, chief business officer and chief operating officer, and was instrumental in financial and business development transactions that raised over $350 million. At Arsanis, Mr. Gray will lead financial strategy, planning and operations as well as corporate and business development initiatives as the company continues to advance its deep clinical and pre-clinical pipeline of precision monoclonal antibodies for serious infectious diseases.
Research Interest
business and management
